Content continues after advertisement

Anticonvulsants with Dr. Barnes

Heidi L. Barnes Heller, DVM, DACVIM (Neurology), Barnes Veterinary Specialty Services, Madison, Wisconsin

podcast

In this episode, host Alyssa Watson, DVM, talks with Heidi L. Barnes Heller, DVM, DACVIM, about her recent Clinician’s Brief article, “Anticonvulsants.” Dr. Barnes reviews some available resources on managing seizures in dogs and the necessary difficulty of extrapolating those to cats. She then dives into the discussion about phenobarbital, potassium bromide, levetiracetam, and zonisamide. Load up on all this seizure knowledge!

Resource

Contact us:

Where to find us:

  • Cliniciansbrief.com/podcasts
  • Facebook.com/clinciansbrief
  • Twitter: @cliniciansbrief
  • Instagram: @clinicians.brief

The Team:

  • Alyssa Watson, DVM - Host
  • Alexis Ussery - Producer & Digital Content Coordinator
  • Randall Stupka - Podcast Production & Sound Editing
Subscribe on your favorite podcast platform.

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Podcasts

Clinician's Brief:
The Podcast

Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Privacy Policy (Updated 01/07/2022) Acceptable Use Policy (Updated 11/22/2021)